Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1177/10600280231164500

Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1341-1342
Number of pages	2
Journal	Annals of Pharmacotherapy
Volume	57
Issue number	11
Early online date	31 Mar 2023
DOIs	https://doi.org/10.1177/10600280231164500
Publication status	Published - 1 Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/10600280231164500Licence: Unspecified

Cite this

@article{dd8ff0179f304e319b6a3f47536c9e6b,

title = "Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19",

keywords = "COVID-19, Thrombosis, Tocilizumab",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad}",

year = "2023",

month = nov,

day = "1",

doi = "10.1177/10600280231164500",

language = "English",

volume = "57",

pages = "1341--1342",

journal = "DICP, Annals of Pharmacotherapy",

issn = "1060-0280",

publisher = "SAGE Publications",

number = "11",

}

TY - JOUR

T1 - Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

PY - 2023/11/1

Y1 - 2023/11/1

KW - COVID-19

KW - Thrombosis

KW - Tocilizumab

UR - http://www.scopus.com/inward/record.url?scp=85152270496&partnerID=8YFLogxK

U2 - 10.1177/10600280231164500

DO - 10.1177/10600280231164500

M3 - Letter

VL - 57

SP - 1341

EP - 1342

JO - DICP, Annals of Pharmacotherapy

JF - DICP, Annals of Pharmacotherapy

SN - 1060-0280

IS - 11

ER -

Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

UN SDGs

Access to Document

Other files and links

Cite this